Amantadine in malignant neuroleptic syndrome
Rojtman, M.; Apter, E.; Lahav, S.; Tiano, S.
Harefuah 100(7): 333
1981
ISSN/ISBN: 0017-7768 PMID: 6115795 Document Number: 180354
Document emailed within 1 workday
Related Documents
Blümlein, G. 1997: Successful use of amantadine in treatment of malignant neuroleptic syndrome Psychiatrische Praxis 24(5): 257-258McCarron, M.M.; Boettger, M.L.; Peck, J.J. 1982: A case of neuroleptic malignant syndrome successfully treated with amantadine Journal of Clinical Psychiatry 43(9): 381-382
Lavie, C.J.; Olmsted, T.R.; Ventura, H.O.; Lepler, B.J. 1986: Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents? Postgraduate Medicine 80(3): 171-178
Fernández, M.; Lago, L.; Alonso, M.Gema.; Guede, A.; Benavente, J.Luis.; Olivares, J.M. 2018: Serotonin syndrome versus neuroleptic malignant syndrome: a case report Actas Espanolas de Psiquiatria 46(2): 68-74
Kimsey, L.R.; Gibbs, J.T.; Glen, R.S.; Markette, J.R.; Kosted, E. 1983: The neuroleptic malignant syndrome Texas Medicine 79(10): 54-55
Martínez, E.; Domingo, P.; Lloret, J. 1994: Malignant neuroleptic syndrome Medicina Clinica 102(5): 181-188
Vallance, H.; McConachie, I. 1993: Neuroleptic malignant syndrome and ECT British Journal of Hospital Medicine 49(1): 50
Hernández, A.F. 1994: The neuroleptic malignant syndrome Medicina Clinica 103(14): 559
Casas Fernández-Tejerina, J.; Pérez de Diego, I.; Estrada Castrillo, P.; Merino Angulo, J. 1987: Neuroleptic malignant syndrome Revista Clinica Espanola 180(7): 407-408
Johannessen, J.O.; Bergrem, H. 1989: Neuroleptic malignant syndrome Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 109(6): 696-697
Segado Soriano, A.; López Gonzalez-Cobos, C.; Villalba Garciá, M.V.; Gil Gómez, J.; Muiño Miguez, A.; Millan Núñez-Cortés, J. 1997: Malignant neuroleptic syndrome Anales de Medicina Interna 14(5): 231-235
Till, E.; Vucković, S.; Lisulov, R.; Nedić, A. 1989: The neuroleptic malignant syndrome Medicinski Pregled 42(11-12): 419-423
Suchanová, L. 1985: Malignant neuroleptic syndrome Ceskoslovenska Psychiatrie 81(2): 91-95
Müller, T.; Becker, T.; Fritze, J. 1989: Neuroleptic malignant syndrome Deutsche Medizinische Wochenschrift 114(11): 442-443
Kishida, I.; Furuno, T.; Kawanishi, C. 2012: Neuroleptic malignant syndrome (NMS) Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 6): 612-615
Courtine, J.C.; Blot, P. 1981: Malignant neuroleptic syndrome La Nouvelle Presse Medicale 10(21): 1749
Retamal, P. 1990: Neuroleptic malignant syndrome Revista Medica de Chile 118(6): 679-685
Bidzińska, E. 1986: Malignant neuroleptic syndrome Psychiatria Polska 20(6): 483-488
Solders, G.; Hedlund, R.; Engvall, P.; Wernerman, J. 1988: Neuroleptic malignant syndrome with rhabdomyolysis and compartment syndrome Lakartidningen 85(6): 445; 447
Al-Waneen, R. 2000: Neuroleptic malignant syndrome associated with quetiapine Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 45(8): 764-765